Nov 12, 2022 | Biologics, MedBen Rx
From earlier this year: “The global biologics market is expected to see a 12% growth rate and reach $420.55 billion by 2025, according to a new report by The Business Research Company.” A drug therapy originating from living organisms, biologics is a...
Oct 18, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending, Savings, White paper
Major pharmacy benefit managers (PBMs) use “smoke and mirrors” to make you believe they’re saving you money on prescription drugs: On the one hand, PBMs offer you administrative fee credits – fixed cost reductions that make up just a small...
Oct 3, 2022 | Health systems, MedBen Rx, Own Use, Savings
Hospitals and other qualified entities have a unique opportunity for pharmacy savings through Own Use. This innovative program can save MedBen Rx clients as much as 35% when compared to standard PBM pricing.Own Use brings together non-profit health care systems and...
Aug 8, 2022 | Comparative Effectiveness, Drug marketing, Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates
From Benefits Pro: “The median launch price of a new drug in the US soared from $2,115 in 2008 to $180,007 in 2021, a 20% annual inflation rate over the period, researchers at Harvard-affiliated Brigham and Women’s Hospital in Boston found.”Contributing to these...
Jul 12, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, Rx prices, Savings, White paper
MedBen Rx has prepared a whitepaper detailing the games pharmacy benefit managers (PBMs) play with administrative and rebate credits. PBMs focus on fixed cost savings to make you think you’re saving on prescription costs… but a closer look reveals that you’re...
